Complex multifactorial prediction model for life-threatening ventricular arrhythmias in patients with myocardial infarction
https://doi.org/10.15829/1728-8800-2025-4215
EDN: OODLYB
Abstract
Aim. To identify markers of ventricular tachycardia (VT), as well as to create a multifactorial prediction model for arrhythmic events in inpatients with myocardial infarction (MI).
Material and methods. The study included 80 patients with MI aged 55,6±8,7 years. The following examination was carried out on days 7-9 of MI: echocardiography, assessment of global longitudinal strain (GLS), contrast-enhanced cardiac magnetic resonance imaging (MRI), determination of N-terminal pro-brain natriuretic peptide (NT-proBNP). During 72-hour electrocardiographic (ECG) monitoring, we detected VT runs, as well as analyzed microvolt T-wave alternans (TWA), heart rate turbulence, late ventricular potentials, heart rate variability, cardiac chronotropic load, and QT dispersion. The end point was the presence of ≥1 VT episode (≥3 QRS complexes) according to multi-day ECG monitoring data.
Results. Nonsustained VT runs were recorded in 10 (12,5%) patients, who made up the VT group. The remaining 70 (87,5%) people who did not have VT episodes were included in the comparison group. MRI data established that the scar tissue mass (36,8±23,7 g) and percentage (28,5±19,8%) in the VT group was higher than in the comparison group (16,9 (6,5; 27,9) g (p=0,025) and 13,3 (5,8; 22,2)% (p=0,045), respectively).
Univariate regression analysis revealed following factors associated with the VT risk: history of coronary artery disease, high NT-proBNP values, heart rate turbulence, microvolt TWA, end diastolic dimension, GLS, scar tissue mass, scar area from total myocardial mass (%), night-time heart rate variability parameters — ULfP, TINN, SDANN.
Conclusion. A multifactorial model for predicting non-sustained VT in patients with MI is proposed, including the following parameters: end-diastolic dimension, MAT, NT-proBNP, GLS, scar tissue mass, and history of coronary artery disease.
Keywords
About the Authors
E. V. AveryanovaRussian Federation
Penza
A. A. Tonkoglaz
Russian Federation
Penza
A. A. Chernova
Russian Federation
Penza
N. A. Donetskaya
Russian Federation
Penza
V. E. Oleynikov
Russian Federation
Penza
References
1. Ageeva LI, Aleksandrova GA, Golubev NA, et al. Zdravooxranenie v Rossii. 2021: Stat.sb./Rosstat. M., 2021. 71 p. (In Russ.) https://rosstat.gov.ru.
2. Aleksandrova GA, Axmetzyanova RR, Golubev NA, et al. Zdravooxranenie v Rossii. 2023: Stat.sb./Rosstat. M., 2023. 179 p. (In Russ.) https://rosstat.gov.ru.
3. Haqqani HM, Marchlinski FE. Electrophysiologic substrate underlying postinfarction ventricular tachycardia: characterization and role in catheter ablation. Heart rhythm. 2009;6(8 Suppl):70-6. doi:10.1016/j.hrthm.2009.04.023.
4. Donahue JK, Chrispin J, Ajijola OA. Mechanism of Ventricular Tachycardia Occurring in Chronic Myocardial Infarction Scar. Circ Res. 2024;134(3):328-42. doi:10.1161/CIRCRESAHA.123.321553.
5. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. New Engl J Med. 2005;352(25):2581-8. doi:10.1056/NEJMoa043938.
6. Adabag AS, Therneau TM, Gersh BJ. Sudden death after myocardial infarction. JAMA. 2008;300(17):2022-9. doi:10.1001/jama.2008.553.
7. Mäkikallio TH, Barthel P, Schneider R, et al. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006;97(4):480-4. doi:10.1016/j.amjcard.2005.09.077.
8. Lebedeva NB, Talibullin IV, Temnikova TB, et al. Clinical and anamnestic characteristics of patients with implanted cardioverter defibrillator in real clinical practice (data from the Kuzbass Registry). Kardiologiia. 2021;61(8):40-7. (In Russ.) doi:10.18087/cardio.2021.8.n1651.
9. Oleynikov VE, Rogoza AN, Averyanova EV, et al. The advantages of multi-day telemetric monitoring of an electrocardiogram in patients who have suffered a myocardial infarction. Cardiological Bulletin. 2024;19(2):39-46. (In Russ.) doi:10.17116/Cardiobulletin20241902139.
10. Barbarash OL, Duplyakov DV, Zatejshchikov DA, et al. Acute coronary syndrome without ST segment elevation electrocardiogram. Clinical guidelines 2020. Russian Journal of Cardiology. 2021;26(4):4449. (In Russ.) doi:10.15829/1560-4071-2021-4449.
11. Russian Society of Cardiology. 2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.) doi:10.15829/29/1560-4071-2020-4103.
12. Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007;153(1):29-35. doi:10.1016/j.ahj.2006.10.004.
13. Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiacmonitoring/telemetry. Heart Rhythm. 2017;14(7):55-96. doi:10.1016/j.hrthm.2017.03.038.
14. Hoshida K, Miwa Y, Miyakoshi M, et al. Simultaneous assessment of T-wave alternans and heart rate turbulence on holter electrocardiograms as predictors for serious cardiac events in patients after myocardial infarction. Circ J. 2013;7(2):432-8. doi:10.1253/circj.cj-12-0789.
15. Lebedev DS, Mihajlov EN, Neminushchij NM, et al. Ventricular arrhythmias. Ventricular tachycardia and sudden cardiac death. Clinical guidelines 2020. Russian Journal of Cardiology. 2021;26(7):4600. (In Russ.) doi:10.15829/1560-4071-2021-4600.
16. Nikoo MH, Naeemi R, Moarefl A, et al. Global longitudinal strain for prediction of ventricular arrhythmia in patients with heart failure. ESC Heart Fail. 2020;7(5):2956-61. doi:10.1002/ehf2.12910.
17. Weissler-Snir A, Hindieh W, Spears DA, et al. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study. J Cardiovasc Electrophysiol. 2019;30(5):651-7. doi:10.1111/jce.13855.
18. Alexandre J, Saloux E, Dugué AE, et al. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long-term appropriate ICD therapy in patients with coronary artery disease. J Cardiovasc Magn Reson. 2013;15(1):12. doi:10.1186/1532-429X-15-12.
19. Guo D, Hu H, Zhao Z, et al. [Value of myocardial scar in predicting malignant ventricular arrhythmia in patients with chronic myocardial infarction]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2019;48(5):511-6. Chinese. doi:10.3785/j.issn.1008-9292.2019.10.08.
Supplementary files
What is already known about the subject?
- The main mechanism of thanatogenesis of sudden cardiac death is life-threatening ventricular arrhythmias.
- Ventricular tachycardia (VT) in patients with myocardial infarction (MI) is transient, so it is not always possible to record it.
What might this study add?
- The main factors associated with the risk of nonsustained VT in patients with MI were identified.
- A comprehensive multifactorial model for predicting the nonsustained VT in patients with MI at the hospital stage was proposed.
Review
For citations:
Averyanova E.V., Tonkoglaz A.A., Chernova A.A., Donetskaya N.A., Oleynikov V.E. Complex multifactorial prediction model for life-threatening ventricular arrhythmias in patients with myocardial infarction. Cardiovascular Therapy and Prevention. 2025;24(1):4215. (In Russ.) https://doi.org/10.15829/1728-8800-2025-4215. EDN: OODLYB